- Home
- WERN vs CMPS Comparison
WERN vs CMPS Comparison
Compare WERN & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WERN | CMPS |
|---|---|---|
| Founded | 1956 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WERN | CMPS |
|---|---|---|
| Price | $32.77 | $10.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 16 |
| Target Price | ★ $41.13 | $23.75 |
| AVG Volume (30 Days) | 727.9K | ★ 2.5M |
| Earning Date | 10-27-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $2,974,396,000.00 | N/A |
| Revenue This Year | $22.79 | N/A |
| Revenue Next Year | $8.00 | N/A |
| P/E Ratio | $1,112.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.06 | $4.88 |
| 52 Week High | $47.49 | $15.87 |
Technical Indicators
Market Signals| Indicator | WERN | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 33.56 |
| Support Level | $32.60 | $10.66 |
| Resistance Level | $32.95 | $14.74 |
| Average True Range (ATR) | 0.89 | 0.57 |
| MACD | 0.09 | -0.11 |
| Stochastic Oscillator | 25.16 | 2.34 |
Price Performance
Historical ComparisonAbout WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.